Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Neurocrine Biosciences and Arena establish research collaboration

Sep. 17, 1999

New transdermal drug delivery system receives U.S. patent coverage

Sep. 16, 1999

Diversa awarded SBIR grants

Sep. 15, 1999

Novel photoprobe for locating sites of action of general anesthetics

Sep. 14, 1999

CAT and AstraZeneca form antibody research collaboration

Sep. 9, 1999

Novartis initiates clinical trials using Emisphere's oral drug delivery technology

Sep. 9, 1999

Lexicon Genetics grants sublicense to Avatar BioSci for use of gene-trapping technology

Sep. 9, 1999

Theratechnologies and Atrix sign bone research collaboration

Sep. 9, 1999

Potent, selective human beta3-adrenoceptor antagonists discovered at Merck & Co.

Sep. 7, 1999

Celera Genomics and Gemini Research establish research collaboration

Sep. 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...